Preliminary Program
- Session times are Korea Standard Time (UTC/GMT+9). Please click the Time Zone Converter button and check your local time.
- The program is subject to change.
- If you click the session code, it will lead you to details of the Scientific Programs.
- We will notify you later about the details of the poster/oral presentation.
To Be Updated
SESSION CODE:
[PL] Plenary Lecture, [SS] Scientific Symposium, [JS] Joint Symposium, [ES] Education Session,
[MDCD] Multi-Disciplinary Case Discussion, [OP] Oral Presentation, [LS] Luncheon Symposium, [SL] Satellite Symposium
| Sep.3 (WED) | Date | Sep.4 (THU) | ||||
|---|---|---|---|---|---|---|
| Room D (Walker Hall 2) |
Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
| 08:40-10:10 | JS 01 ASCO/KSMO |
JS 02 KCSG/KSMO |
ES 02 | SS 01 | SL 01 (8:40-9:20)  |
|
| SL 02 (9:30-10:10)  |
||||||
| 10:10-10:20 | Break (10 min.) | |||||
| 10:20-10:40 | Opening Ceremony (10:20-10:40) |
|||||
| 10:40-11:20 | PL 01 | |||||
| 11:20-11:30 | Break (10 min.) | |||||
| 11:30-12:10 | LS 01 |
LS 02 |
LS 03 |
LS 04 |
LS 05 |
|
| 12:10-12:20 | Break (10 min.) | |||||
| 12:20-13:50 | SS 02 | ES 03 | SS 03 | JS 03 KOSRO/KSMO |
SL 03 (12:20-13:00) |
|
| SL 04 (13:10-13:50)  |
||||||
| 13:50-14:00 | Break (10 min.) | |||||
| KSMO Initiatives for Cancer Care Inequity (14:00-16:00) |
14:00-15:30 | JS 04 ESMO/KSMO |
JS 05 KSSO/KSMO |
ES 04 | SS 04 | SL 05 (14:00-14:40)  |
| SL 06 (14:50-15:30)  |
||||||
| 15:30-15:40 | Break (10 min.) | |||||
| 15:40-16:20 | PL 02 | |||||
| Break (10 min.) | ||||||
| ES 01 (16:10-17:30) |
||||||
| 16:20-17:50 | SS 05 | OP 01 16:20-17:20 |
SS 06 | JS 06 KSR/KSMO |
SL 07 (16:20-17:00)  |
|
| Break (10 min.) | ||||||
| Welcome Reception (Room C, Walker Hall 1) |
PD01 17:20~17:50 Exhibition Hall |
SL 08 (17:10-17:50)  |
||||
| Date | Sep.5 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
| 08:40-10:10 | JS 07 JSMO/KSMO |
ES 05 | SS 07 | JS 08 KSP/KSMO |
SL 09 (8:40-9:20)  |
| SL 10 (9:30-10:10)  |
|||||
| 10:10-10:30 | Break (20 min.) | ||||
| 10:30-11:10 | PL 03 | ||||
| 11:10-11:30 | Break (20 min.) | ||||
| 11:30-12:10 | LS 06 |
LS 07 |
LS 08 |
LS 09 |
LS 10 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | JS 09 ASCO/KSMO |
OP 02 12:20-13:20 |
MDCD | SS 08 | SL 11 (12:20-13:00)  |
| PD02 13:20~13:50 Exhibition Hall |
SL 12 (13:10-13:50) |
||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-14:40 | PL 04 | |
||||
| 14:40-14:50 | Break (10 min.) | ||||
| 14:50-16:20 | JS 10 ESMO/KSMO |
SS 09 | SS 10 | SL 13 (14:50-15:30)  |
|
| SL 14 (15:40-16:20)  |
|||||
| 16:20-16:40 | Closing Ceremony | ||||
| Date | Sep.3 (WED) |
|---|---|
| Time | Room D (Walker Hall 2) |
| 14:00-16:00 | KSMO Initiatives for Cancer Care Inequity |
| 16:00-16:10 | Break (10 min.) |
| 16:10-17:30 | ES 01 Symptom management in advanced cancer: Innovations and best practices |
| 17:30-17:40 | Break (10 min.) |
| 17:40~ | Welcome Reception (Room C, Walker Hall 1) |
| Date | Sep.4 (THU) | ||||
|---|---|---|---|---|---|
| Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
| 08:40-10:10 | JS 01 ASCO/KSMO New horizon on gastroesophageal cancer treatment |
JS 02 KCSG/KSMO Transforming Oncology Research: AI-Powered Clinical Trials |
ES 02 Tumor heterogeneity and single-cell analysis KOR |
SS 01 Optimizing the transition to palliative care: Prognostic estimation and communication in oncology |
SL 01 (8:40-9:20) |
| SL 02 (9:30-10:10) |
|||||
| 10:10-10:20 | Break (10 min.) | ||||
| 10:20-10:40 | Opening Ceremony (10:20-10:40) |
||||
| 10:40-11:20 | PL 01 Breaking new ground: Innovative cancer vaccine therapies |
||||
| 11:20-11:30 | Break (10 min.) | ||||
| 11:30-12:10 | LS 01 |
LS 02 |
LS 03 |
LS 04 |
LS 05 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | SS 02 Revolutionizing GI cancer care with next-generation modalities |
ES 03 Cancer survivorship: Shifting paradigms in care KOR |
SS 03 How shall we treat RARE cancer in the era of precision medicine : Progress and challenges ahead |
JS 03 KOSRO/KSMO Optimization of neoadjuvant/adjuvant treatment |
SL 03 (12:20-13:00) |
| SL 04 (13:10-13:50) |
|||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-15:30 | JS 04 ESMO/KSMO ESMO guideline and the implementation in Asian Pacific Region |
JS 05 KSSO/KSMO Omit surgery in GI cancer treatment |
ES 04 Toxicity management in Antibody-Drug Conjugates (ADCs) KOR |
SS 04 Current trends and future perspectives in GU oncology |
SL 05 (14:00-14:40) |
| SL 06 (14:50-15:30) |
|||||
| 15:30-15:40 | Break (10 min.) | ||||
| 15:40-16:20 | PL 02 Cancer cachexia: Transition from science to practice |
||||
| 16:20-17:50 | SS 05 Current insights and future directions of MBC treatment |
OP 01 16:20-17:20 |
SS 06 Clinical promise of ctDNA-based MRD testing in solid tumors |
JS 06 KSR/KSMO Radiomics revolution: AI and imaging in cancer care |
SL 07 (16:20-17:00) |
| PD01 17:20~17:50 Exhibition Hall |
SL 08 (17:10-17:50) |
||||
| Date | Sep.5 (FRI) | ||||
|---|---|---|---|---|---|
| Time | Room A (Vista Hall 1) |
Room B (Vista Hall 3) |
Room C (Walker Hall 1) |
Room D (Walker Hall 2) |
Room E (Grand Hall 4) |
| 08:40-10:10 | JS 07 JSMO/KSMO The new standard therapy in solid tumors : The combination of immunotherapies |
ES 05 Advance of technology - Artificial Intelligence in Oncology KOR |
SS 07 Novel opportunities to target cancer: Emerging strategies in molecular oncology |
JS 08 KSP/KSMO Biomarker for ADC |
SL 09 (8:40-9:20) |
| SL 10 (9:30-10:10) |
|||||
| 10:10-10:30 | Break (20 min.) | ||||
| 10:30-11:10 | PL 03 Advances in chemotherapy for gastric cancer- Future perspectives |
||||
| 11:10-11:30 | Break (20 min.) | ||||
| 11:30-12:10 | LS 06 |
LS 07 |
LS 08 |
LS 09 |
LS 10 |
| 12:10-12:20 | Break (10 min.) | ||||
| 12:20-13:50 | JS 09 ASCO/KSMO The impact of NGS testing in oncology patients |
OP 02 12:20-13:20 |
MDCD Personalized treatment strategies for oligometastatic patients in the new era of cancer therapeutics KOR |
SS 08 Combinatory strategy to enhance immune checkpoint response |
SL 11 (12:20-13:00) |
| PD02 13:20~13:50 Exhibition Hall |
SL 12 (13:10-13:50) |
||||
| 13:50-14:00 | Break (10 min.) | ||||
| 14:00-14:40 | PL 04 Biomarkers to predict efficacy and toxicity of antibody drug conjugates in breast cancer. |
||||
| 14:40-14:50 | Break (10 min.) | ||||
| 14:50-16:20 | JS 10 ESMO/KSMO How to streamline initiatives for optimising oncology practice |
SS 09 Real-world challenges in GI oncology: Navigating complex treatment decisions |
SS 10 Revealing immune response and resistance through spatial profiling of NSCLC microenvironment |
SL 13 (14:50-15:30) |
|
| SL 14 (15:40-16:20) |
|||||
| 16:20-16:40 | Closing Ceremony | ||||